|
New formulation of ibuprofen on absorption-rate: A comparative bioavailability study in healthy volunteers
|
Yasaman Moghadamnia    , Sohrab Kazemi , Boshra Rezaee , Mehrdad Rafati-Rahimzadeh , Soheil Ebrahimpour , Fahimeh Aghapour |
| Neuroscience Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran , fahim.mfm@gmail.com |
|
|
Abstract: (6304 Views) |
Background: Enteric-coated capsules are solid dosage forms which are designed to bypass the stomach and release the drug in the small intestine. This study was done to compare pharmacokinetics of ibuprofen tablet and ibuprofen as enteric-coated capsule using sodium alginate beads.
Methods: A crossover randomized study was performed on 12 healthy volunteers receiving a single dose of regular ibuprofen tablet (200 mg) and enteric-coated capsule (200 mg). The washout time between the periods was one month. Pharmacokinetic and pharmacodynamic blood samples were collected for 16 hours following treatment. High-performance liquid chromatography (HPLC) method used the following specifications: C18 column with 4.6 mm diameter & 25 mm length, the fluorescent detector of excitation and emission wavelengths were 224 and 290 nm, respectively.
Results: After a single oral dose of ibuprofen formulations, the median times to maximum concentration were 60 and 240 minutes in ibuprofen tablet (200 mg) and enteric-coated capsule, respectively. The maximum levels for the participants receiving ibuprofen tablet and enteric-coated capsule were 11.71±1.3 and 10.32±4.19 µg/mL, respectively. The pharmacokinetic (PK) modeling data showed the area under curve (AUC) to be 61.51 hours & 86.62 hours for the group receiving the tablet and the capsule, respectively.
Conclusion: According to the results, in is concluded that enteric coating may delay the onset of ibuprofen effect and increases the duration of action. This formulation has advantages over the conventional drug delivery systems as it lengthens the dosing intervals and also increases patient compliance for chronic pain. |
|
| Keywords: ibuprofen, pharmacokinetics, COX2-inhibitory effects |
|
|
Full-Text [PDF 595 kb]
(1263 Downloads)
|
Type of Study: Original Article |
Subject:
pharmacology
Received: 2018/06/10 | Accepted: 2018/11/19 | Published: 2019/05/13
|
|
|
|
|
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
